Abstract
The aim of this work was to study the resistance to macrolides (azithromycin) in the modern Russian population of N. gonorrhoeae with the analysis of genetic resistance determinants. Azithromycin is not used to treat gonococcal infection in Russia. However, among 162 isolates collected in 2020–2021, 22 isolates (13.6%) were phenotypically resistant to azithromycin. Mutations in 23S rRNA genes were found only in two isolates; erm and mefA genes were absent. Azithromycin resistance was shown to be predominantly associated with mutations in the mtrR and mtrD genes of the MtrCDE efflux pump and their mosaic alleles which may have formed due to a horizontal transfer from N. meningitidis. A total of 30 types of mtrR alleles and 10 types of mtrD alleles were identified including mosaic variants. Matching between the mtrR and mtrD alleles was revealed to indicate the cooperative molecular evolution of these genes. A link between the mtrR and mtrD alleles and NG-MAST types was found only for NG-MAST 228 and 807, typical of N. gonorrhoeae in Russia. The high level of resistance to azithromycin in Russia may be related to the spread of multiple transferable resistance to antimicrobials regardless of their use in the treatment of gonococcal infection.
Funder
Ministry of Science and Higher Education of the Russian Federation
Ministry of Health of the Russian Federation
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology
Reference34 articles.
1. (2021). The Global Health Sector Strategies 2016–2021: Actions for Impact, World Health Organization.
2. Antimicrobial resistance prediction in Neisseria gonorrhoeae: Current status and future prospects;Golparian;Expert Rev. Mol. Diagn.,2022
3. Shaskolskiy, B., Kandinov, I., Dementieva, E., and Gryadunov, D. (2022). Antibiotic resistance in Neisseria gonorrhoeae: Challenges in research and treatment. Microorganisms, 10.
4. Management of Neisseria gonorrhoeae in the United States: Summary of evidence from the development of the 2020 gonorrhea treatment recommendations and the 2021 Centers for Disease Control and Prevention sexually transmitted infection treatment guidelines;Barbee;Clin. Infect. Dis.,2022
5. (2016). WHO Guidelines for the Treatment of Neisseria gonorrhoeae, World Health Organization.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献